Breaking News

KWS BioTest acquired by Charles River Laboratories

KWS BioTest, a spinout company from the University of Bristol, has been acquired by US-based Charles River Laboratories, ...

Cressall announces global distribution deal with RS Components

Resistor manufacturer Cressall, has signed a new global distribution agreement with electronic and industrial ...

CPI’s National Formulation Centre set to open

The Centre for Process Innovation, the UK’s technology innovation provider for process manufacturing, announced that ...

Machine vision for the future of pharmaceuticals

The pharmaceutical industry is renowned for being competitive; and despite strict administrative regulations, there ...

Carbogen Amcis announces successful Swissmedic inspection

Switzerland-based Carbogen Amcis, a pharmaceutical process development and active pharmaceutical ingredient ...

Pharma market 2020: Upswing turn for global production

Rainer Krugmann, Global Director Sales at Fette Compacting, provides an outlook as to what trends Fette Compacting can ...

Improving cold chain performance and reliability

The need to mitigate risks within global pharmaceutical supply chain logistics is driving innovation within the ...

Another win for CRF Health

CRF Health's 'Outstanding Innovation' with pioneering trialConsent wins 2018 Clinical Informatics News Best Practices ...

Cancer Research UK to invest £45 m in clinical trials

Cancer Research UK has announced that £45 million will be invested into its network of clinical trials units across the ...

Gene transfer therapy approved for the treatment of ALL: part II

In August 2017, Novartis received FDA approval for its chimeric antigen receptor T (CAR-T) cell therapy, Kymriah, for ...

Gene transfer therapy approved for the treatment of ALL: part I

In August 2017, Novartis received FDA approval for its chimeric antigen receptor T (CAR-T) cell therapy, Kymriah, for ...

Expediting time-to-market with big data

For the pharmaceutical sector to truly benefit, data collaboration needs to be incorporated into business as usual

Debiopharm continues fight against antibiotic resistance

Debiopharm Group invests in antibiotic development with the acquisition of a minority stake in ABAC Therapeutics

Allecra announces fast track designation for antibiotic

Allecra Therapeutics, a biopharmaceutical company dedicated to the development of novel antibiotics for the treatment ...